Tricyclic 1,2,4-triazolo-quinazolines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

42424856, 544115, 544119, C07D48704, A61K 31505

Patent

active

040536009

ABSTRACT:
The invention discloses 5-substituted-1,2,4-triazolo[4,3-c]quinazolines and 1,2,4-triazolo[1,5-c]quinazolines having pharmacological activity in animals and useful, for example, as hypotensive and anti-inflammatory agents. The compounds may be prepared, for example, by reacting a 5-halo-1,2,4-triazolo-quinazoline with a compound representing the function to be introduced at the 5-position. The 5-halo-1,2,4-triazolo[4,3-c]quinazolines also have pharmacological activity, e.g., hypotensive and anti-inflammatory activity, and may be prepared by reacting a 4-hydrazino-quinazoline with trimethoxy methane. The 5-halo-1,2,4-triazolo[1,5-c]quinazolines also have hypotensive and anti-inflammatory activity and are prepared from the corresponding 1,2,4-triazolo-[1,5-c]quinazolin-5(1H)-one using phosphorus oxychloride, the quinazolin-5(1H)-one being in turn prepared from the 5-halo-1,2,4-triazolo[4,3-c]quinazoline.

REFERENCES:
patent: 3838126 (1974-09-01), Wagner

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic 1,2,4-triazolo-quinazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic 1,2,4-triazolo-quinazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic 1,2,4-triazolo-quinazolines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-739729

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.